Research ArticleBRAIN
Role of Perfusion CT in Glioma Grading and Comparison with Conventional MR Imaging Features
S.K. Ellika, R. Jain, S.C. Patel, L. Scarpace, L.R. Schultz, J.P. Rock and T. Mikkelsen
American Journal of Neuroradiology November 2007, 28 (10) 1981-1987; DOI: https://doi.org/10.3174/ajnr.A0688
S.K. Ellika
R. Jain
S.C. Patel
L. Scarpace
L.R. Schultz
J.P. Rock
References
- ↵Law M, Yang S, Babb JS, et al. Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast- enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol 2004;25:746–55
- ↵Law M, Cha S, Knopp EA, et al. High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging. Radiology 2002;222:715–21
- ↵Aronen HJ, Gazit IE, Louis DN, et al. Cerebral blood volume maps of gliomas: comparison with tumour grade and histologic findings. Radiology 1994;191:41–51
- ↵Folkman J. The role of angiogenesis in tumor growth. Semin Cancer Biol 1992;3:65–71
- ↵Nugent LJ, Jain RK. Extravascular diffusion in normal and neoplastic tissues. Cancer Res 1984;44:238–44
- ↵Jain RK, Gerlowski LE. Extravascular transport in normal and tumor tissues. Crit Rev Oncol Hematol 1986;5:115–70
- ↵Burger PC, Vogel FS. The brain tumors. In: Burger PC, Vogel FS, eds. Surgical Pathology of the Central Nervous System and its Coverings. New York: Wiley;1982 :223–66
- ↵Knopp EA, Cha S, Johnson G, et al. Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 1999;211:791–98
- ↵Wong JC, Provenzale JM, Petrella JR. Perfusion MR imaging of brain neoplasms. AJR Am J Roentgenol 2000;174:1147–57
- Cha S, Knopp EA, Johnson G, et al. Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology 2002;223:11–29
- ↵Lev MH, Rosen BR. Clinical applications of intracranial perfusion MR imaging. Neuroimaging Clin N Am 1999;9:309–31
- ↵
- Petrella JR, Provenzale JM. MR perfusion imaging of the brain: techniques and applications. AJR Am J Roentgenol 2000;175:207–19
- ↵Law M, Yang S, Wang H, et al. Glioma gradings: specificity and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 2003;24:1989–98
- ↵Sugahara T, Korogi Y, Tomiguchi S, et al. Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue. AJNR Am J Neuroradiol 2000;21:901–09
- ↵
- ↵Dean BL, Drayer BP, Bird CR, et al. Gliomas: classification with MR imaging. Radiology 1990;174:411–15
- ↵Watanabe M, Tanaka R, Takeda N. Magnetic resonance imaging and histopathology of cerebral gliomas. Neuroradiology 1992;34:463–69
- ↵Burger PC, Vogel FS, Green SB, et al. Glioblastoma multiforme and anaplastic astrocytoma: pathologic criteria and prognostic implications. Cancer 1985;56:1106–11
- Burger PC. Malignant astrocytic neoplasms: classification, pathologic anatomy, and response to therapy. Semin Oncol 1986;13:16–26
- ↵Burger PC, Scheithauer BW. Tumors of the Central Nervous System. Washington, DC: Armed Forces Institute of Pathology;1994 :452
- ↵Kelly PJ, Daumas-Duport C, Scheithauer BW, et al. Stereotactic histologic correlations of computed tomography and magnetic resonance imaging-defined abnormalities in patients with glial neoplasms. Mayo Clin Proc 1987;62:450–59
- ↵Jackson RJ, Fuller GN, Abi-Said D, et al. Limitations of stereotactic biopsy in the initial management of gliomas. Neuro-oncol 2001;3:193–200
- ↵Gilles FH, Brown WD, Leviton A, et al. Limitations of the World Health Organization classification of childhood supratentorial astrocytic tumor: Children Brain Tumor Consortium. Cancer 2000;88:1477–83
- ↵
- Johnson JP, Bruce JN. Angiogenesis in human gliomas: prognostic and therapeutic implications. In: Rosen EM, Goldberg D, eds. Regulation of Angiogenesis. Basel, Switzerland: Birkhauser;1997 :29–46
- ↵Lund EL, Spang-Thompsen M, Skovgaard-Poulsen H, et al. Tumor angiogenesis: a new therapeutic target in gliomas. Acta Neurol Scand 1998;97:52–62
- ↵
- ↵Ginsberg LE, Fuller GN, Hashmi M, et al. The significance of lack of MR contrast enhancement of supratentorial brain tumors in adults: histopathological evaluation of a series. Surg Neurol 1998;49:436–40
- ↵Kondziolka D, Lunsford LD, Martinez AJ. Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (low-grade) astrocytoma. J Neurosurg 1993;79:533–36
- ↵Mihara F, Numaguchi Y, Rothman M, et al. Non-contrast-enhancing supratentorial malignant astrocytoma: MR features and possible mechanisms. Radiat Med 1995;13:11–17
- ↵Bagley LJ, Grossman RI, Judy KD, et al. Gliomas: correlation of magnetic susceptibility artifact with histologic grade. Radiology 1997;202:511–16
- ↵Siegal T, Rubinstein R, Tzuk-Shina T, et al. Utility of relative cerebral blood volume mapping derived from perfusion magnetic resonance imaging in the routine follow up of brain tumours. J Neurosurg 1997;86:22–27
- ↵Shimizu H, Kumabe T, Tominaga T, et al. Noninvasive evaluation of malignancy of brain tumors with proton MR spectroscopy. AJNR Am J Neuroradiol 1996;17:737–47
- ↵Henry RG, Vigneron DB, Fischbein NJ, et al. Comparison of relative cerebral blood volume and proton spectroscopy in patients with treated gliomas. AJNR Am J Neuroradiol 2000;21:357–66
- ↵Jackson A, Kassner A, Annesley-Williams D, et al. Abnormalities in the recirculation phase of contrast agent bolus passage in cerebral gliomas: comparison with relative blood volume and tumor grade. AJNR Am J Neuroradiol 2002;23:7–14
- ↵Covarrubias DJ, Rosen BR, Lev MH. Dynamic magnetic resonance perfusion imaging of brain tumors. Oncologist 2004;9:528–37
- ↵Cenic A, Nabavi DG, Craen RA, et al. Dynamic CT measurement of cerebral blood flow: a validation study. AJNR Am J Neuroradiol 1999;20:63–73
- Cenic A, Nabavi DG, Craen RA, et al. A CT method to measure hemodynamics in brain tumors: validation and application of cerebral blood flow maps. AJNR Am J Neuroradiol 2000;21:462–70
- ↵Nabavi DG, Cenic A, Craen RA, et al. CT assessment of cerebral perfusion: experimental validation and initial clinical experience. Radiology 1999;213:141–49
- ↵Wintermark M, Thiran JP, Maeder P, et al. Simultaneous measurement of regional cerebral blood flow by perfusion CT and stable xenon CT: a validation study. AJNR Am J Neuroradiol 2001;22:905–14
- ↵
- ↵Hazle JD, Jackson EF, Schomer DF, et al. Dynamic imaging of intracranial lesions using fast spin-echo imaging: differentiation of brain tumors and treatment effects. J Magn Reson Imaging 1997;7:1084–93
- ↵
- ↵
- ↵Eastwood JD, Provenzale JM. Cerebral blood flow, blood volume, and vascular permeability of cerebral glioma assessed with dynamic CT perfusion imaging. Neuroradiology 2003;45:373–76
In this issue
Advertisement
Role of Perfusion CT in Glioma Grading and Comparison with Conventional MR Imaging Features
S.K. Ellika, R. Jain, S.C. Patel, L. Scarpace, L.R. Schultz, J.P. Rock, T. Mikkelsen
American Journal of Neuroradiology Nov 2007, 28 (10) 1981-1987; DOI: 10.3174/ajnr.A0688
Jump to section
Related Articles
- No related articles found.
Cited By...
- T1-Weighted Dynamic Contrast-Enhanced MRI as a Noninvasive Biomarker of Epidermal Growth Factor Receptor vIII Status
- Comparison of the Diagnostic Accuracy of DSC- and Dynamic Contrast-Enhanced MRI in the Preoperative Grading of Astrocytomas
- Correlation of Perfusion Parameters with Genes Related to Angiogenesis Regulation in Glioblastoma: A Feasibility Study
- Imaging biomarkers of angiogenesis and the microvascular environment in cerebral tumours
- Perfusion CT Imaging of Brain Tumors: An Overview
- Permeability Estimates in Histopathology-Proved Treatment-Induced Necrosis Using Perfusion CT: Can These Add to Other Perfusion Parameters in Differentiating from Recurrent/Progressive Tumors?
- In Vivo Correlation of Tumor Blood Volume and Permeability with Histologic and Molecular Angiogenic Markers in Gliomas
This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.
- Nishant Verma, Matthew C. Cowperthwaite, Mark G. Burnett, Mia K. MarkeyNeuro-Oncology 2013 15 5
- Avinash R. Kambadakone, Dushyant V. SahaniRadiologic Clinics of North America 2009 47 1
- Koichi Mitsuya, Yoko Nakasu, Satoshi Horiguchi, Hideyuki Harada, Tetsuo Nishimura, Etsuro Bando, Hiroto Okawa, Yoshihiro Furukawa, Tatsuo Hirai, Masahiro EndoJournal of Neuro-Oncology 2010 99 1
- R. Jain, S.K. Ellika, L. Scarpace, L.R. Schultz, J.P. Rock, J. Gutierrez, S.C. Patel, J. Ewing, T. MikkelsenAmerican Journal of Neuroradiology 2008 29 4
- Alan Siu, Joshua J. Wind, J. Bryan Iorgulescu, Timothy A. Chan, Yoshiya Yamada, Jonathan H. ShermanActa Neurochirurgica 2012 154 2
- Shin-Ichi MIYATAKE, Noasuke NONOGUCHI, Motomasa FURUSE, Erina YORITSUNE, Tomo MIYATA, Shinji KAWABATA, Toshihiko KUROIWANeurologia medico-chirurgica 2015 55 1
- R. Jain, J. Gutierrez, J. Narang, L. Scarpace, L.R. Schultz, N. Lemke, S.C. Patel, T. Mikkelsen, J.P. RockAmerican Journal of Neuroradiology 2011 32 2
- R. JainAmerican Journal of Neuroradiology 2011 32 9
- G Thompson, S J Mills, D J Coope, J P B O’connor, A JacksonThe British Journal of Radiology 2011 84 special_issue_2
- Hung-Wen Kao, Shih-Wei Chiang, Hsiao-Wen Chung, Fong Y. Tsai, Cheng-Yu ChenBioMed Research International 2013 2013
More in this TOC Section
Similar Articles
Advertisement